Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Cannabinoid Receptor I ELISA Kit (AC3949)
Cat.#: ASET-2538
Specifications
Description Human Cannabinoid Receptor I ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Cannabinoid Receptor I concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.14 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 3-48 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2284 Rat Angiogenin ELISA Kit (AC3695) Quantitative inquiry ASET-1031 Mouse Prealbumin ELISA Kit (AC2442) Quantitative inquiry ASET-2318 Human Semaphorin 3A ELISA Kit (AC3729) Quantitative inquiry ASET-1872 Human 5HT1A Receptor ELISA Kit (AC3283) Quantitative inquiry ASET-2424 Human Noelin ELISA Kit (AC3835) Quantitative inquiry ASET-2227 Human PON2 ELISA Kit (AC3638) Quantitative inquiry ASET-1837 Mouse Nogo ELISA Kit (AC3248) Quantitative inquiry ASET-1026 Human Cadherin 8 ELISA Kit (AC2437) Quantitative inquiry ASET-2297 Human LAR ELISA Kit (AC3708) Quantitative inquiry ASET-1625 Human TDP43 ELISA Kit (AC3036) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket